Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2019 at "Oncology"
DOI: 10.1159/000502384
Abstract: Introduction: Neuroendocrine tumors (NETs) are a heterogeneous group of malignancies with various clinical presentations and growth rates. NET incidence has been estimated to 2.5–5 per 100,000 people per year, and NET prevalence is 35 per… read more here.
Keywords: synchronous cancers; patients neuroendocrine; metachronous synchronous; neuroendocrine tumors ... See more keywords